Ingevity Corp. Files Q3 2024 10-Q Report
Ticker: NGVT · Form: 10-Q · Filed: 2024-10-30T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, earnings, financials, chemicals
TL;DR
Ingevity's Q3 2024 10-Q is in, check the numbers for performance materials and pavement tech.
AI Summary
Ingevity Corp. reported its third-quarter results for the period ending September 30, 2024. The company's financial performance for the quarter and year-to-date is detailed in this 10-Q filing. Specific financial figures and operational metrics are provided for the third quarter of 2024 and comparative periods.
Why It Matters
This filing provides investors and analysts with the latest financial performance data for Ingevity Corp., crucial for understanding the company's current health and future prospects.
Risk Assessment
Risk Level: medium — The filing contains detailed financial information which, while informative, can also reveal potential risks or challenges faced by the company.
Key Numbers
- 2024 Q3 — Reporting Period (Third quarter of 2024)
- 2024-09-30 — Period End Date (End of the fiscal quarter)
- 2023-09-30 — Prior Year Period End (Comparison point for Q3 2024)
Key Players & Entities
- Ingevity Corp. (company) — Filer of the 10-Q report
- 20240930 (date) — End of the reporting period
- 20241030 (date) — Filing date
- 2024-09-30 (date) — End of the reporting period
- 2023-09-30 (date) — Comparative reporting period
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is the quarter ended September 30, 2024.
When was this 10-Q filing submitted to the SEC?
This 10-Q filing was submitted on October 30, 2024.
What are the two main business segments mentioned in the filing data?
The filing data mentions 'PerformanceMaterialsMember' and 'PavementTechnologiesMember' as key segments.
What fiscal year end does Ingevity Corp. have?
Ingevity Corp.'s fiscal year ends on December 31.
What is the company's primary industry classification?
Ingevity Corp. is classified under 'CHEMICALS & ALLIED PRODUCTS [2800]'.
Filing Stats: 4,627 words · 19 min read · ~15 pages · Grade level 7.9 · Accepted 2024-10-30 16:21:03
Key Financial Figures
- $0.01 — ange on which registered Common Stock ($0.01 par value) NGVT New York Stock Exchange
Filing Documents
- ngvt-20240930.htm (10-Q) — 1799KB
- ex101-psususemployees.htm (EX-10.1) — 48KB
- ex102-psusukemployees.htm (EX-10.2) — 83KB
- ex311-q32024.htm (EX-31.1) — 10KB
- ex312-q32024.htm (EX-31.2) — 10KB
- ex321-q32024.htm (EX-32.1) — 4KB
- ex322-q32024.htm (EX-32.2) — 4KB
- ngvt-20240930_g1.jpg (GRAPHIC) — 143KB
- 0001653477-24-000100.txt ( ) — 10752KB
- ngvt-20240930.xsd (EX-101.SCH) — 57KB
- ngvt-20240930_cal.xml (EX-101.CAL) — 102KB
- ngvt-20240930_def.xml (EX-101.DEF) — 269KB
- ngvt-20240930_lab.xml (EX-101.LAB) — 604KB
- ngvt-20240930_pre.xml (EX-101.PRE) — 472KB
- ngvt-20240930_htm.xml (XML) — 2207KB
- FINANCIAL INFORMATION
PART I - FINANCIAL INFORMATION 3
Financial Statements
Item 1. Financial Statements 3 Condensed Consolidated Statements of Operations 3 Condensed Consolidated Statements of Comprehensive Income (Loss) 4 Condensed Consolidated Balance Sheets 5 Condensed Consolidated Statements of Cash Flows 6 Notes to the Condensed Consolidated Financial Statements 7
Management's Discussion and Analysis of Financial Condition and Results of Operations
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 29
Quantitative and Qualitative Disclosures About Market Risk
Item 3. Quantitative and Qualitative Disclosures About Market Risk 44
Controls and Procedures
Item 4. Controls and Procedures 45
- OTHER INFORMATION
PART II - OTHER INFORMATION 46
Legal Proceedings
Item 1. Legal Proceedings 46
Risk Factors
Item 1A. Risk Factors 46
Unregistered Sales of Equity Securities and Use of Proceeds
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 47
Defaults Upon Senior Securities
Item 3. Defaults Upon Senior Securities 47
Mine Safety Disclosures
Item 4. Mine Safety Disclosures 47
Other Information
Item 5. Other Information 47
Exhibits
Item 6. Exhibits 48
SIGNATURES
SIGNATURES 49 2
- FINANCIAL INFORMATION
PART I - FINANCIAL INFORMATION
FINANCIAL STATEMENTS
ITEM 1. FINANCIAL STATEMENTS INGEVITY CORPORATION Condensed Consolidated Statements of Operations (Unaudited) Three Months Ended September 30, Nine Months Ended September 30, In millions, except per share data 2024 2023 2024 2023 Net sales $ 376.9 $ 446.0 $ 1,107.6 $ 1,320.4 Cost of sales 247.0 317.0 754.8 908.0 Gross profit 129.9 129.0 352.8 412.4 Selling, general, and administrative expenses 38.7 40.0 127.3 140.3 Research and technical expenses 6.7 7.8 20.8 24.6 Restructuring and other (income) charges, net 86.9 24.6 162.8 49.4 Goodwill impairment charge — — 349.1 — Acquisition-related costs ( 0.1 ) 0.1 — 3.8 Other (income) expense, net 111.8 1.3 167.9 ( 13.9 ) Interest expense, net 23.8 23.1 69.3 64.3 Income (loss) before income taxes ( 137.9 ) 32.1 ( 544.4 ) 143.9 Provision (benefit) for income taxes ( 30.7 ) 6.9 ( 97.5 ) 32.5 Net income (loss) $ ( 107.2 ) $ 25.2 $ ( 446.9 ) $ 111.4 Per share data Basic earnings (loss) per share $ ( 2.95 ) $ 0.70 $ ( 12.31 ) $ 3.05 Diluted earnings (loss) per share ( 2.95 ) 0.69 ( 12.31 ) 3.03 The accompanying notes are an integral part of these financial statements. 3 INGEVITY CORPORATION Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) Three Months Ended September 30, Nine Months Ended September 30, In millions 2024 2023 2024 2023 Net income (loss) $ ( 107.2 ) $ 25.2 $ ( 446.9 ) $ 111.4 Other comprehensive income (loss), net of tax: Foreign currency adjustments: Foreign currency translation adjustment 34.8 ( 21.4 ) 23.1 ( 6.9 ) Total foreign currency adjustments, net of tax provision (benefit) of zero for all periods 34.8 ( 21.4 ) 23.1 ( 6.9 ) Derivative instruments: Unrealized gain (loss), net of tax provision (benefit) of $( 0.4 ), $( 0.1 ), $( 0.5 ), and $( 0.8 ) ( 1.6 ) ( 0.1 ) ( 1.8 ) ( 2.5 ) Reclassifications of deferred derivative instruments (gain) loss, included in net income (loss), net of tax (provision) benefit of $ 0.1 , $ 0.3 , $ 0.5 , and $